본문 바로가기

Enhanced Efficacy of Therapeutic Cancer Vaccines Produced by Co-Treatment with Mycobacterium tuberculosis Heparin-Binding Hemagglutinin, a Novel TLR4 Agonist

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1
저널
CANCER RESEARCH71(8) · pp.2858 · 2011
피인용
Web of Science 78
JCR IF
JCR 2010 8.234
ISSN
0008-5472

저자

  1. 정인덕제1저자부산대학교, 부속연구소, 양산병원 의생명융합연구소, KO
  2. 정수경부산대학교, 의과대학, 의학과, KO
  3. 이창민부산대학교, 의과대학, 의학과, KO
  4. 노경태부산대학교, 의과대학, 의학과, KO
  5. 허덕림부산대학교, 의과대학, 의학과, KO
  6. Shin, Yong Kyoo중앙대학교, Coll Med, Dept Pharmacol, KO
  7. Yun, Cheol-Heui서울대학교, Res Inst Agr & Life Sci, KO
  8. Koh, Won-Jung성균관대학교, Sch Med, Samsung Med Ctr, KO
  9. Akira, Shizuo오사카대학, Host Def Lab, WPI Immunol Frontier Res Ctr, JA
  10. Whang, Jake충남대학교, Dept Microbiol, Coll Med, KO
  11. Kim, Hwa-Jung충남대학교, Dept Microbiol, Coll Med, KO
  12. Park, Won Sun강원대학교, Dept Physiol, Sch Med, KO
  13. Shin, Sung Jae충남대학교, Dept Microbiol, Coll Med, KO
  14. 박영민A교신저자부산대학교, 의과대학, 의학과, KO

초록

Effective activation of dendritic cells (DCs) toward T helper (Th)-1 cell polarization would improve DC-based antitumor immunotherapy, helping promote the development of immunotherapeutic vaccines based on T-cell immunity. To achieve this goal, it is essential to develop effective immune adjuvants that can induce powerful Th1 cell immune responses. The pathogenic organism Mycobacterium tuberculosis includes certain constitutes, such as heparin-binding hemagglutinin (HBHA), that possess a strong immunostimulatory potential. In this study, we report the first clarification of the functions and precise mechanism of HBHA in immune stimulation settings relevant to cancer. HBHA induced DC maturation in a TLR4-dependent manner, elevating expression of the surface molecules CD40, CD80, and CD86, MHC classes I and II and the proinflammatory cytokines IL-6, IL-12, IL-1 beta, TNF-alpha, and CCR7, as well as stimulating the migratory capacity of DCs in vitro and in vivo. Mechanistic investigations established that MyD88 and TRIF signaling pathways downstream of TLR4 mediated secretion of HBHA-induced proinflammatory cytokines. HBHA-treated DCs activated naive T cells, polarized CD4(+) and CD8(+) T cells to secrete IFN-gamma, and induced T-cell-mediated cytotoxicity. Notably, systemic administration of DCs that were HBHA-treated and OVA(251-264)-pulsed ex vivo greatly strengthened immune priming in vivo, inducing a dramatic regression of tumor growth associated with long-term survival in a murine E.G7 thymoma model. Together, our findings highlight HBHA as an immune adjuvant that favors Th1 polarization and DC function for potential applications in DC-based antitumor immunotherapy. Cancer Res; 71(8); 2858-70. (C)2011 AACR.

키워드

ACTIVATED PROTEIN-KINASETOLL-LIKE RECEPTORST-CELL RESPONSESDENDRITIC CELLSEXTRAPULMONARY DISSEMINATIONADAPTIVE IMMUNITYCARCINOMA-CELLSINNATE IMMUNITYANTIGENIMMUNOTHERAPY

식별자

WoS UID
000289507800007